Oetgen Stephen Duane
SEC Form 4 insider trading activity
Oetgen Stephen Duane has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Apr 20, 2026.
On the most recent filing, Oetgen Stephen Duane is listed as Director at Arxis, Inc. Inside the rolling window, Oetgen Stephen Duane reported 1 open-market purchase totaling $700K in ARXS and no open-market sales.
Companies traded
Other insiders at ARXS
Insider Buying
$700K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Oetgen Stephen Duane made?
Oetgen Stephen Duane has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2026.
Which companies does Oetgen Stephen Duane trade?
Oetgen Stephen Duane has filed SEC Form 4 disclosures for 1 company, including ARXS.
When was Oetgen Stephen Duane's most recent SEC Form 4 filing?
Oetgen Stephen Duane's most recent SEC Form 4 filing on Tracefour is dated Apr 20, 2026.
What is Oetgen Stephen Duane's total buy and sell value in the current window?
Inside the rolling retention window, Oetgen Stephen Duane bought $700K and sold $0 based on SEC Form 4 filings.
What was Oetgen Stephen Duane's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 25,000 ARXS shares on 2026-04-17, worth $700K, per SEC Form 4 filings.